MI4A Vaccine Purchase Database

The Market Information for Access (MI4A) vaccine purchase database is the output of a peer platform leveraging data collected from countries worldwide. Since 2017, this comprehensive country-based dataset has gathered information on global vaccine markets , with more than 190 Member States reporting on over 1000 unique products across 96 vaccine types. Countries report through the WHO/UNICEF Joint Reporting Form annually, hence the dataset is updated every year and includes historic data.  Through the MI4A Initiative the WHO Global Access team makes this dataset publicly available to equip countries and vaccine market actors with market intelligence that can inform product choice, support financial planning, help optimize budgets, enhance procurement and strengthen national, regional and global decision-making for improved access to vaccines.

Information available through the dataset includes information on every vaccine that each country has purchased, including:

• Country income group and region (NB: country names are anonymized due to confidentiality);
• Vaccine product, presentation, price, volume, procurement channel, contract details.
  
  

2026 MI4A Public Vaccine Purchase Dataset: Vaccine price ranges by product, procurement mechanism and income group

This table provides a summary overview of price ranges paid for different vaccines by different countries in 2025, including the minimum and maximum price per dose, based on data collected and published as part of the MI4A 2026 Vaccine Purchase Dataset. Countries are grouped according to:

1. Procurement channel (UNICEF Supply Division, PAHO Revolving Fund, Self-procuring): Refers to the mechanism by which the vaccine was purchased.
2. Classification by World Bank (LIC/LMIC/UMIC/HIC): Categorization into income levels according to gross national income (GNI) per capita in US$.
3. Gavi eligibility (Gavi-eligible or Non-Gavi eligible): Categorization according to country’s eligibility to receive Gavi support for vaccines in 2026.

The Min / Max values in the table correspond to US$ per dose for the respective vaccine and country group.

The table is non-exhaustive and is representative of minimum and maximum prices based on what has been reported by countries. Variations in prices may also be due to different vaccine presentations, manufacturing brands, as well as other factors.